MiMedx Group (MDXG) vs Sight Sciences (SGHT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sight Sciences (SGHT) has outperformed MiMedx Group (MDXG) over the past year, gaining 163.0% versus a loss of 34.9%. Over five years, MDXG leads with a -31.7% price change compared with -58.7% for SGHT. MiMedx Group is the larger company by market cap ($681.5 million vs $489.7 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDXG | SGHT |
|---|---|---|
| Share price | $4.67 | $8.89 |
| Market cap | $681.51M | $489.73M |
| 1-day change | +1.08% | +4.96% |
| YTD return | -31.76% | +12.11% |
| 1-year return | -34.93% | +163.02% |
| 5-year return | -31.66% | -58.65% |
| P/E ratio (TTM) | 116.75 | — |
| Forward P/E | 23.35 | — |
| EPS (TTM) | $0.04 | $-0.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.97 | $9.71 |
| 52-week low | $3.03 | $3.19 |
| Distance from 52-week high | -41.41% | -8.47% |
| Analyst consensus | none | buy |
| Avg. price target upside | +58.46% | +5.74% |
| Average volume | 1.23M | 258.30K |
| Shares outstanding | 145.93M | 55.09M |
| Employees | 808 | 186 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SGHT has outperformed MDXG by 197.9 percentage points over the past year.
About MiMedx Group
MDXG stock →MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Health Care · Medical/Dental Instruments · 808 employees
About Sight Sciences
SGHT stock →Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.
Health Care · Medical/Dental Instruments · 186 employees
MDXG vs SGHT FAQ
Which is bigger, MiMedx Group or Sight Sciences?
MiMedx Group (MDXG) is larger, with a market capitalization of $681.51M compared with $489.73M for Sight Sciences (SGHT).
Which stock has performed better over the past year, MDXG or SGHT?
SGHT returned +163.02% over the past 12 months, compared with -34.93% for MDXG (price return, excluding dividends). Past performance does not predict future results.
Are MiMedx Group and Sight Sciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.